235 related articles for article (PubMed ID: 20351309)
1. An exquisite cross-control mechanism among endothelial cell fate regulators directs the plasticity and heterogeneity of lymphatic endothelial cells.
Kang J; Yoo J; Lee S; Tang W; Aguilar B; Ramu S; Choi I; Otu HH; Shin JW; Dotto GP; Koh CJ; Detmar M; Hong YK
Blood; 2010 Jul; 116(1):140-50. PubMed ID: 20351309
[TBL] [Abstract][Full Text] [Related]
2. COUP-TFII orchestrates venous and lymphatic endothelial identity by homo- or hetero-dimerisation with PROX1.
Aranguren XL; Beerens M; Coppiello G; Wiese C; Vandersmissen I; Lo Nigro A; Verfaillie CM; Gessler M; Luttun A
J Cell Sci; 2013 Mar; 126(Pt 5):1164-75. PubMed ID: 23345397
[TBL] [Abstract][Full Text] [Related]
3. Prox1 physically and functionally interacts with COUP-TFII to specify lymphatic endothelial cell fate.
Lee S; Kang J; Yoo J; Ganesan SK; Cook SC; Aguilar B; Ramu S; Lee J; Hong YK
Blood; 2009 Feb; 113(8):1856-9. PubMed ID: 18815287
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate.
Diez H; Fischer A; Winkler A; Hu CJ; Hatzopoulos AK; Breier G; Gessler M
Exp Cell Res; 2007 Jan; 313(1):1-9. PubMed ID: 17045587
[TBL] [Abstract][Full Text] [Related]
5. The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells.
Srinivasan RS; Geng X; Yang Y; Wang Y; Mukatira S; Studer M; Porto MP; Lagutin O; Oliver G
Genes Dev; 2010 Apr; 24(7):696-707. PubMed ID: 20360386
[TBL] [Abstract][Full Text] [Related]
6. COUP-TFII is a major regulator of cell cycle and Notch signaling pathways.
Chen X; Qin J; Cheng CM; Tsai MJ; Tsai SY
Mol Endocrinol; 2012 Aug; 26(8):1268-77. PubMed ID: 22734039
[TBL] [Abstract][Full Text] [Related]
7. COUP-TFII regulates the functions of Prox1 in lymphatic endothelial cells through direct interaction.
Yamazaki T; Yoshimatsu Y; Morishita Y; Miyazono K; Watabe T
Genes Cells; 2009 Mar; 14(3):425-34. PubMed ID: 19210544
[TBL] [Abstract][Full Text] [Related]
8. Opposing regulation of PROX1 by interleukin-3 receptor and NOTCH directs differential host cell fate reprogramming by Kaposi sarcoma herpes virus.
Yoo J; Lee HN; Choi I; Choi D; Chung HK; Kim KE; Lee S; Aguilar B; Kang J; Park E; Lee YS; Maeng YS; Kim NY; Koh CJ; Hong YK
PLoS Pathog; 2012; 8(6):e1002770. PubMed ID: 22719258
[TBL] [Abstract][Full Text] [Related]
9. COUP-TFII switches responses of venous endothelium to atherosclerotic factors through controlling the profile of various inherent genes expression.
Wu X; Zou Y; Liang Y; Zhou Q; Gong H; Sun A; Yuan L; Wang K; Ge J
J Cell Biochem; 2011 Jan; 112(1):256-64. PubMed ID: 21069739
[TBL] [Abstract][Full Text] [Related]
10. Notch1, Jagged1, and HES5 are abundantly expressed in osteoarthritis.
Karlsson C; Brantsing C; Egell S; Lindahl A
Cells Tissues Organs; 2008; 188(3):287-98. PubMed ID: 18354251
[TBL] [Abstract][Full Text] [Related]
11. Impact of Hey2 and COUP-TFII on genes involved in arteriovenous differentiation in primary human arterial and venous endothelial cells.
Korten S; Brunssen C; Poitz DM; Großklaus S; Brux M; Schnittler HJ; Strasser RH; Bornstein SR; Morawietz H; Goettsch W
Basic Res Cardiol; 2013 Jul; 108(4):362. PubMed ID: 23744056
[TBL] [Abstract][Full Text] [Related]
12. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells.
Harrington LS; Sainson RC; Williams CK; Taylor JM; Shi W; Li JL; Harris AL
Microvasc Res; 2008 Mar; 75(2):144-54. PubMed ID: 17692341
[TBL] [Abstract][Full Text] [Related]
13. Microfibril-associate glycoprotein-2 (MAGP-2) promotes angiogenic cell sprouting by blocking notch signaling in endothelial cells.
Albig AR; Becenti DJ; Roy TG; Schiemann WP
Microvasc Res; 2008 May; 76(1):7-14. PubMed ID: 18417156
[TBL] [Abstract][Full Text] [Related]
14. Notch1 functions as a negative regulator of lymphatic endothelial cell differentiation in the venous endothelium.
Murtomaki A; Uh MK; Choi YK; Kitajewski C; Borisenko V; Kitajewski J; Shawber CJ
Development; 2013 Jun; 140(11):2365-76. PubMed ID: 23615281
[TBL] [Abstract][Full Text] [Related]
15. A study on Notch signaling in human breast cancer.
Zang S; Ji Ch; Qu X; Dong X; Ma D; Ye J; Ma R; Dai J; Guo D
Neoplasma; 2007; 54(4):304-10. PubMed ID: 17822320
[TBL] [Abstract][Full Text] [Related]
16. Notch1 signaling in FIZZ1 induction of myofibroblast differentiation.
Liu T; Hu B; Choi YY; Chung M; Ullenbruch M; Yu H; Lowe JB; Phan SH
Am J Pathol; 2009 May; 174(5):1745-55. PubMed ID: 19349363
[TBL] [Abstract][Full Text] [Related]
17. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
[TBL] [Abstract][Full Text] [Related]
18. DLL4/Notch1 and BMP9 Interdependent Signaling Induces Human Endothelial Cell Quiescence via P27KIP1 and Thrombospondin-1.
Rostama B; Turner JE; Seavey GT; Norton CR; Gridley T; Vary CP; Liaw L
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2626-37. PubMed ID: 26471266
[TBL] [Abstract][Full Text] [Related]
19. High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer.
Izrailit J; Berman HK; Datti A; Wrana JL; Reedijk M
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1714-9. PubMed ID: 23319603
[TBL] [Abstract][Full Text] [Related]
20. Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma.
Teider N; Scott DK; Neiss A; Weeraratne SD; Amani VM; Wang Y; Marquez VE; Cho YJ; Pomeroy SL
Neuro Oncol; 2010 Dec; 12(12):1244-56. PubMed ID: 20847082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
